Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug 1;35(4):295-301.
doi: 10.1097/QCO.0000000000000843. Epub 2022 Jul 5.

COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US

Alberto Mussetti  1   2 , Zinaida Peric  3 , Cesar Figueroa  4   5
Affiliations
Review

COVID19 in hematological patients and telemedicine: lessons learned across Europe and the US

Alberto Mussetti et al. Curr Opin Infect Dis. .

Abstract

Purpose of review: To describe the state-of-the-art of telemedicine in hematology through the description of most relevant studies published in the pre-COVID19 and during the COVID19 era.

Recent findings: Telemedicine has recently gained momentum in hematology due to the COVID19 pandemic. Due to a necessary improvement of domiciliary follow-up of patients during the pandemic and an increase in technologies able to offer telemedicine, the number of studies has increased in the last 2 years. Telemedicine showed the potential to improve the monitoring of both benign and malignant hematological diseases. Patients affected by thalassemias, hemophilias and/or myeloproliferative diseases were monitored successfully with telemedicine platform. For higher-risk patients such as high-dose chemotherapy or stem cell transplantation, better platforms are needed (e.g. use of wearable devices systems). Also, telemedicine showed to be useful for the follow-up of hematological patients with COVID19.

Summary: Despite the clear potential advantages of telemedicine for the follow-up of hematological patients, more evidence is required before adopting this approach in larger cohorts of patients. Larger- and higher-quality studies are highly needed in this setting.

PubMed Disclaimer

References

    1. What is Digital Health? 2021; published online April. https://www.fda.gov/medical-devices/digital-health-center-excellence/wha...
    1. Chen CE, Harrington RA, Desai SA, et al. Characteristics of digital health studies registered in ClinicalTrials.gov. JAMA Intern Med 2019; 179:838.
    1. American Telehealth Association. https://www.americantelemed.org/resource/why-telemedicine/ . [Accessed 28 February 2022]
    1. Shah AC, O’Dwyer LC, Badawy SM. Telemedicine in malignant and nonmalignant hematology: systematic review of pediatric and adult studies. JMIR Mhealth Uhealth 2021; 9:e29619.
    1. Grading of Recommendations Assessment, Development and Evaluation (short GRADE) working group. https://www.gradeworkinggroup.org/ . [Accessed 28 February 2022]